Not All Bruton’s Tyrosine Kinase Inhibitors are Created Equal: Pharmacologic Insights into the Efficacy, Resistance, and Safety of Covalent and Non-covalent BTK Inhibitors. Canadian Hematology Today, Toronto, Canada, v. 5, n. s02, p. 2–7, 2026. DOI: 10.58931/cht.2026.5s0282. Disponível em: https://canadianhematologytoday.com/article/view/5-s02-Minotti. Acesso em: 21 may. 2026.